What patients and families need to know
New approaches to relapsed childhood leukemia
Amanda Toll Lecture: New Approaches to Relapsed Childhood Leukemia
Lia Gore, MD
Professor of Pediatrics, Medical Oncology and Hematology
University of Colorado School of Medicine | Anschutz Medical Campus
Co-Director, Hematological Malignancies Program, University of Colorado Comprehensive Cancer Center;
Chief, Pediatric Hematology/Oncology/Bone Marrow Transplant; The Robert J. and Kathleen A. Clark and Ergen Family Endowed Chairs; Children's Hospital Colorado, Center for Cancer and Blood Disorders
Therapy for children with acute lymphoblastic leukemia (ALL) has changed dramatically over the past 40 years, and while initially a nearly universally fatal disease, it is now one of the most highly curable forms of cancer. Through cooperative clinical trials across the world, outcomes for children with cancer are better than ever before and more and more adults are now survivors of childhood ALL, which changes the landscape of health across age groups.
Attendees of this session will be able to:
- Describe changes in the outcomes of childhood acute lymphoblastic leukemia (ALL) over the past 40 years
- Discuss some reasons for improvements in childhood cancer therapy.
- Describe new approaches to the treatment of childhood ALL and how they may potentially impact the outcomes for children diagnosed today.
Make an Appointment
Share your birthday with a child. Celebrate your life, and give a chance to someone who desperately wants to have as many as you.
Make it happen